| Trial ID: | L4582 |
| Source ID: | NCT01581736
|
| Associated Drug: |
U100 Humulin
|
| Title: |
Molecular Regulation of Muscle Glucose Metabolism
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Obesity|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: U100 Humulin|OTHER: Exercise
|
| Outcome Measures: |
Primary: insulin sensitivity, euglycemic clamp, one month from date of volunteer study | Secondary: acetylation of mitochondrial adenine nucleotide translocase, proteomics analysis of post translational modification of proteins obtained from isolated mitochondria, within 6 months of volunteer study
|
| Sponsor/Collaborators: |
Sponsor: Mayo Clinic | Collaborators: Arizona State University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-04
|
| Completion Date: |
2016-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-11-27
|
| Locations: |
Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01581736
|
